Website
Founded
2018
Location
2002 Timberloch Place
The Woodlands, Texas,
United States of America
BusinessWire
Fuzionaire Radioisotope Technologies K.K. and Nihon Medi-Physics Enter Feasibility Study Agreement
January 26th, 2021
bioworld
Fuzionaire, Canadian researchers shine light on neurodegenerative diseases
David Godkin – February 28th, 2020
parkinsonsnewstoday
Collaboration Formed to Develop New Radiochemicals for Diagnosing, Treating Brain Diseases
Patricia Inacio, PHD – February 5th, 2020
dotmed
Three-way collaboration to introduce radiopharmaceuticals for brain diseases
John R. Fischer – February 3rd, 2020
Dr. Waldmann is a radiopharmacist and scientist with more than a decade of experience in radiopharmaceutical manufacturing and development. As a postdoc at UCLA’s Crump Institute for Molecular Imaging, Dr. Waldmann invented the HetSiFA technology in collaboration with the laboratory of Nobel Laureate Robert H. Grubbs at Caltech. The invention constitutes the scientific basis of Fuzionaire Diagnostics. He previously was the Head of Radiochemistry at the University Medical Center Mainz, Germany, where he manufactured radiopharmaceuticals for diagnostic and therapeutic applications. Dr. Waldmann continues to be an advisor to the University Medical Center and holds a scientific affiliation there. His research focuses on the development of radiopharmaceuticals for theranostic applications in oncology. He is the author of a chapter in the textbook Molecular Imaging in Oncology, and his work has been published in leading academic journals including Theranostics, PNAS and Nature.